BPC-157 (Cognitive Applications)

A 15-amino acid partial sequence of human gastric juice body protection compound. While primarily categorized as a healing and recovery peptide, BPC-157 demonstrates significant neuroprotective and neuroregenerative properties relevant to cognitive enhancement, including dopaminergic system modulation, traumatic brain injury recovery, and nerve growth support. Cross-reference with the healing-recovery category for its primary tissue-repair profile.

• Modulates the dopamine D1 and D2 receptor systems, counteracting dopamine agonist and antagonist-induced disturbances
• Promotes nitric oxide (NO) system mediated neuroprotection and angiogenesis in neural tissue
• Activates FAK-paxillin pathway to support nerve cell survival and regeneration
• Interacts with the GABAergic system, contributing to anxiolytic and mood-stabilizing effects

• Active malignancy, particularly CNS tumors
• Pregnancy or breastfeeding
• Currently taking dopamine-modulating medications (potential for interaction)

Store at 2–8°C (36–46°F) for up to 3 months. For long-term storage, keep at -20°C (-4°F). Once reconstituted, refrigerate and use within 21 days. Relatively stable peptide.

Reconstitute lyophilized powder with bacteriostatic water. For cognitive applications, intranasal and subcutaneous routes are most commonly used in research. Oral capsule forms are also available.

BPC-157 has been studied extensively in preclinical models for its neuroprotective properties beyond its well-known tissue healing effects. Research published in journals including Current Neuropharmacology and Regulatory Peptides has demonstrated its ability to counteract dopaminergic neurotoxicity (amphetamine, haloperidol), protect against traumatic brain injury, and promote peripheral nerve regeneration following transection injuries. Its interaction with the NO system and dopamine pathways makes it relevant to cognitive function, though human clinical trials for cognitive indications have not been conducted.